197 related articles for article (PubMed ID: 1976735)
1. Human immunodeficiency virus type 1-infected individuals make autoantibodies that bind to CD43 on normal thymic lymphocytes.
Ardman B; Sikorski MA; Settles M; Staunton DE
J Exp Med; 1990 Oct; 172(4):1151-8. PubMed ID: 1976735
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies directed against CD43 molecules with an altered glycosylation status on human immunodeficiency virus type 1 (HIV-1)-infected CEM cells are found in all HIV-1+ individuals.
Giordanengo V; Limouse M; Desroys du Roure L; Cottalorda J; Doglio A; Passeron A; Fuzibet JG; Lefebvre JC
Blood; 1995 Sep; 86(6):2302-11. PubMed ID: 7662977
[TBL] [Abstract][Full Text] [Related]
3. Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line.
Lefebvre JC; Giordanengo V; Limouse M; Doglio A; Cucchiarini M; Monpoux F; Mariani R; Peyron JF
J Exp Med; 1994 Nov; 180(5):1609-17. PubMed ID: 7964449
[TBL] [Abstract][Full Text] [Related]
4. Enhanced susceptibility to human immunodeficiency virus infection in CD4+ T lymphocytes genetically deficient in CD43.
Srinivas RV; Su T; Trimble LA; Lieberman J; Ardman B
AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1015-21. PubMed ID: 8554898
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of T-cell activation by the CD43 molecule whose expression is defective in Wiskott-Aldrich syndrome.
Park JK; Rosenstein YJ; Remold-O'Donnell E; Bierer BE; Rosen FS; Burakoff SJ
Nature; 1991 Apr; 350(6320):706-9. PubMed ID: 2023632
[TBL] [Abstract][Full Text] [Related]
6. Parallel pattern of expression of CD43 and of LFA-1 on the CD45RA+ (naive) and CD45RO+ (memory) subsets of human CD4+ and CD8+ cells. Correlation with the aggregative response of the cells to CD43 monoclonal antibodies.
Youseffi-Etemad R; Axelsson B
Immunology; 1996 Mar; 87(3):439-46. PubMed ID: 8778031
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of mononuclear cell activation by an anti-CD43 (sialophorin) agonistic antibody.
Silverman LB; Wong RC; Remold-O'Donnell E; Vercelli D; Sancho J; Terhorst C; Rosen F; Geha R; Chatila T
J Immunol; 1989 Jun; 142(12):4194-200. PubMed ID: 2542404
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of CD43-hexasaccharide isoform on peripheral T lymphocytes from HIV-infected individuals.
Gallego MD; Aguado E; Kindelán JM; Peña J; Santamaría M; Molina IJ
AIDS; 2001 Mar; 15(4):477-81. PubMed ID: 11242144
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a 95 kDa human leucocyte sialoglycoprotein: its identity with CD43, gpL115, leukosialin and sialophorin.
Stefanová I; Hilgert I; Angelisová P; Kristofová H; Horejsí V
Folia Biol (Praha); 1988; 34(4):255-65. PubMed ID: 2467832
[TBL] [Abstract][Full Text] [Related]
10. Induction of aggregation and enhancement of proliferation and IL-2 secretion in human T cells by antibodies to CD43.
Axelsson B; Youseffi-Etemad R; Hammarström S; Perlmann P
J Immunol; 1988 Nov; 141(9):2912-7. PubMed ID: 3049818
[TBL] [Abstract][Full Text] [Related]
11. CD43 diminishes susceptibility to T lymphocyte-mediated cytolysis.
McFarland TA; Ardman B; Manjunath N; Fabry JA; Lieberman J
J Immunol; 1995 Feb; 154(3):1097-104. PubMed ID: 7822786
[TBL] [Abstract][Full Text] [Related]
12. The CBF.78 monoclonal antibody to human sialophorin has distinct properties giving new insights into the CD43 marker and its activation pathway.
Tkaczuk J; Al Saati T; Escargueil-Blanc I; Salvayre A; Horejsi V; Durand M; de Preval C; Ohayon E; Delsol G; Abbal M
Tissue Antigens; 1999 Jul; 54(1):1-15. PubMed ID: 10458318
[TBL] [Abstract][Full Text] [Related]
13. Production and the characterization of monoclonal antibody against CD43, K06.
Park WS; Chae JS; Jung KC; Choi WJ; Kook MC; Bae Y
Tissue Antigens; 2004 Jan; 63(1):46-53. PubMed ID: 14651523
[TBL] [Abstract][Full Text] [Related]
14. Expression of the T antigen on a T-lymphoid cell line, supT1.
Nakada H; Inoue M; Tanaka N; Wakamiya N; Yamashina I
Glycoconj J; 1995 Jun; 12(3):356-9. PubMed ID: 7496150
[TBL] [Abstract][Full Text] [Related]
15. Expression characteristics and stimulatory functions of CD43 in human CD4+ memory T cells: analysis using a monoclonal antibody to CD43 that has a novel lineage specificity.
Kyoizumi S; Ohara T; Kusunoki Y; Hayashi T; Koyama K; Tsuyama N
J Immunol; 2004 Jun; 172(12):7246-53. PubMed ID: 15187099
[TBL] [Abstract][Full Text] [Related]
16. Engagement of CD43 enhances human immunodeficiency virus type 1 transcriptional activity and virus production that is induced upon TCR/CD3 stimulation.
Barat C; Tremblay MJ
J Biol Chem; 2002 Aug; 277(32):28714-24. PubMed ID: 12045189
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the activation-associated isoform of CD43 on murine T lymphocytes.
Jones AT; Federsppiel B; Ellies LG; Williams MJ; Burgener R; Duronio V; Smith CA; Takei F; Ziltener HJ
J Immunol; 1994 Oct; 153(8):3426-39. PubMed ID: 7523493
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against sialophorin (CD43) enhance the capacity of dendritic cells to cluster and activate T lymphocytes.
Fanales-Belasio E; Zambruno G; Cavani A; Girolomoni G
J Immunol; 1997 Sep; 159(5):2203-11. PubMed ID: 9278308
[TBL] [Abstract][Full Text] [Related]
19. Persistent superphosphorylation of leukosialin (CD43) in activated T cells and in tumour cell lines.
Axelsson B; Perlmann P
Scand J Immunol; 1989 Nov; 30(5):539-47. PubMed ID: 2531463
[TBL] [Abstract][Full Text] [Related]
20. Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death.
Lantéri M; Giordanengo V; Hiraoka N; Fuzibet JG; Auberger P; Fukuda M; Baum LG; Lefebvre JC
Glycobiology; 2003 Dec; 13(12):909-18. PubMed ID: 12925577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
